These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1549653)

  • 1. New directions in the development of MR imaging contrast media.
    Brasch RC
    Radiology; 1992 Apr; 183(1):1-11. PubMed ID: 1549653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph node metastases from gastric cancer: gadofluorine M and gadopentetate dimeglumine MR imaging in a rabbit model.
    Lee JY; Choi BI; Son KR; Lee JM; Kim SJ; Park HS; Chang JM; Choi SH; Kim MA; Moon WK
    Radiology; 2012 May; 263(2):391-400. PubMed ID: 22517957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update: safety, new applications, new MR agents.
    Runge VM; Wells JW
    Top Magn Reson Imaging; 1995; 7(3):181-95. PubMed ID: 7654396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Magnetic resonance tomography in myocardial ischemia: state of the art].
    Szolar DH; Saeed M; Higgins CB
    Rofo; 1996 Sep; 165(3):216-26. PubMed ID: 8924680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR contrast agents for liver imaging: what, when, how.
    Gandhi SN; Brown MA; Wong JG; Aguirre DA; Sirlin CB
    Radiographics; 2006; 26(6):1621-36. PubMed ID: 17102040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concepts of myocardial perfusion imaging in magnetic resonance imaging.
    Wilke N; Jerosch-Herold M; Stillman AE; Kroll K; Tsekos N; Merkle H; Parrish T; Hu X; Wang Y; Bassingthwaighte J
    Magn Reson Q; 1994 Dec; 10(4):249-86. PubMed ID: 7873354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anatomic and functional evaluation of the lymphatics and lymph nodes in diagnosis of lymphatic circulation disorders with contrast magnetic resonance lymphangiography.
    Liu NF; Lu Q; Jiang ZH; Wang CG; Zhou JG
    J Vasc Surg; 2009 Apr; 49(4):980-7. PubMed ID: 19223143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced MR imaging of the heart: overview of the literature.
    Edelman RR
    Radiology; 2004 Sep; 232(3):653-68. PubMed ID: 15284429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contrast products in magnetic resonance imaging].
    Bonnemain B
    Ann Pharm Fr; 1994; 52(5):229-39. PubMed ID: 7857031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast agents for MR imaging of the liver.
    Balci NC; Semelka RC
    Radiol Clin North Am; 2005 Sep; 43(5):887-98, viii. PubMed ID: 16098345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadobutrol for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison with gadopentetate dimeglumine.
    Durmus T; Schilling R; Doeblin P; Huppertz A; Hamm B; Taupitz M; Wagner M
    Invest Radiol; 2012 Mar; 47(3):183-8. PubMed ID: 22183078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualization of normal and interrupted lymphatic drainage in dog legs with interstitial MR lymphography using an extracellular MR contrast agent, gadopentetate dimeglumine.
    Suga K; Yuan Y; Ogasawara N; Okada M; Matsunaga N
    Invest Radiol; 2003 Jun; 38(6):349-57. PubMed ID: 12908702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR imaging in the evaluation of hepatic metastases.
    Imam K; Bluemke DA
    Magn Reson Imaging Clin N Am; 2000 Nov; 8(4):741-56. PubMed ID: 11149677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of viable and nonviable myocardium at MR imaging: comparison of gadolinium-based extracellular and blood pool contrast materials versus manganese-based contrast materials in a rat myocardial infarction model.
    Flacke S; Allen JS; Chia JM; Wible JH; Periasamy MP; Adams MD; Adzamli IK; Lorenz CH
    Radiology; 2003 Mar; 226(3):731-8. PubMed ID: 12601183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance enhancement pattern and diagnostic accuracy of gadofluorine M in a rabbit VX2 tumor model: Comparison with gadopentetate dimeglumine.
    Kim SJ; Moon WK; Choi SH; Chang JM; Cho N
    Eur J Radiol; 2012 Aug; 81(8):1751-7. PubMed ID: 21477960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of cerebral metastases on magnetic resonance imaging: intraindividual comparison of gadobutrol with gadopentetate dimeglumine.
    Anzalone N; Gerevini S; Scotti R; Vezzulli P; Picozzi P
    Acta Radiol; 2009 Oct; 50(8):933-40. PubMed ID: 19626475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal liver lesions: SPIO-, gadolinium-, and ferucarbotran-enhanced dynamic T1-weighted and delayed T2-weighted MR imaging in rabbits.
    Schnorr J; Wagner S; Abramjuk C; Drees R; Schink T; Schellenberger EA; Pilgrimm H; Hamm B; Taupitz M
    Radiology; 2006 Jul; 240(1):90-100. PubMed ID: 16684917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Optimal use of contrast medium in contrast enhanced MR imaging of the heart].
    Sakuma H
    Nihon Igaku Hoshasen Gakkai Zasshi; 2002 Oct; 62(12):682-9. PubMed ID: 12462069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced MR imaging of postoperative scars and VX2 carcinoma in rabbits: comparison of macromolecular contrast agent and gadopentetate dimeglumine.
    Lee JW; Moon WK; Weinmann HJ; Kim SJ; Kim JH; Park SH; Kim TJ; Yoon CJ; Kim YH; Cho EY; Ha SW; Kang WS; Chang KH
    Radiology; 2003 Oct; 229(1):132-9. PubMed ID: 14519873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced liver MR: contrast agents and imaging strategy.
    Runge VM; Kirsch JE; Wells JW; Awh MH; Bittner DF; Woolfolk CE
    Crit Rev Diagn Imaging; 1993; 34(1-2):1-30. PubMed ID: 8216813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.